External Beam Radiotherapy as Curative Treatment of Prostate Cancer

Pisansky, Thomas M.
July 2005
Mayo Clinic Proceedings;Jul2005, Vol. 80 Issue 7, p883
Academic Journal
External beam radiotherapy (RT) has been used as a curative treatment of prostate cancer for more than 5 decades, with the ‘modern’ era emerging more than 3 decades ago. Its history is marked by gradual improvements punctuated by several quantum leaps that are increasingly driven by advancements in the computer and imaging sciences and by its integration with complementary forms of treatment. Consequently, the contemporary use of external beam RT barely resembles its earliest form, and this must be appreciated in the context of current patient care. The Influence of predictive factors on the use and outcomes of external beam RT is presented, as is a selected review of the methods and outcomes of external beam RT as a single therapeutic Intervention, in association with androgen suppression, or as a postoperative adjunct. Thus, the ‘state of the (radiotherapeutic) art’ is presented to enhance the understanding of this treatment approach with the hope that this information will serve as a useful resource to physicians as they care for patients with prostate cancer.


Related Articles

  • Brachy therapy for prostate cancer: Early indian experience. Shankar, L. S.; Mahadev, P. // Indian Journal of Urology;Supplement1, Vol. 24, pS6 

    Between January 2006 and June 2007 16 patients with localised cancer prostate were treated with hdr (monotherapy) radiotherapy. Our patient details, procedural aspects and early results will be discussed.

  • Biochemical and clinical outcomes after high-dose salvage radiotherapy as monotherapy for prostate cancer. Botticella, Angela; Guarneri, Alessia; Levra, Niccolo'; Munoz, Fernando; Filippi, Andrea; Rondi, Nadia; Badellino, Serena; Arcadipane, Francesca; Levis, Mario; Ragona, Riccardo; Ricardi, Umberto // Journal of Cancer Research & Clinical Oncology;Jul2014, Vol. 140 Issue 7, p1111 

    Purpose: To retrospectively evaluate the role of high-dose salvage radiotherapy (SRT) alone with regard to biochemical and clinical outcomes in patients with biochemical failure (BF) after radical prostatectomy (RP). Methods: Between January 2003 and August 2011, 168 hormone-naïve localized...

  • 1st Belgian patient treated via RapidArc.  // Medical Device Daily;2/6/2009, Vol. 13 Issue 24, p7 

    The article reports on the treatment of the first prostate cancer patient at the University Hospital of Leuven, Belgium. The treatment involved the use of the faster form of radiotherapy with the RapidArc technology from Varian Medical Systems. The patient is a retired military aircraft...

  • Early clinical experience of radiotherapy of prostate cancer with volumetric modulated arc therapy. Pesce, Gianfranco A.; Clivio, Alessandro; Cozzi, Luca; Nicolini, Giorgia; Richetti, Antonella; Salati, Emanuela; Valli, Mariacarla; Vanetti, Eugenio; Fogliata, Antonella // Radiation Oncology;2010, Vol. 5, p54 

    Background: To report about initial clinical experience in radiation treatment of carcinoma of prostate with volumetric modulated arcs with the RapidArc (RA) technology. Methods: Forty-five patients with a median age of 72 ± 3, affected by prostate carcinoma (T1c: 22 patients, T2a-b: 17...

  • Shorter Radiation Course May Improve PCa Control. SCHIESZER, JOHN // Renal & Urology News;Jan2010, Vol. 9 Issue 1, p15 

    The article focuses on the findings of a study related to the use of hypofractionated stereotactic body radiotherapy in the treatment of high-risk prostate cancer. The study revealed that hypofractionated radiation treatment can improve outcomes in the prostate cancer patients. Researcher,...

  • Does Radiotherapy for the Primary Tumor Benefit Prostate Cancer Patients with Distant Metastasis at Initial Diagnosis? Cho, Yeona; Chang, Jee Suk; Rha, Koon Ho; Hong, Sung Joon; Choi, Young Deuk; Ham, Won Sik; Kim, Jun Won; Cho, Jaeho // PLoS ONE;1/25/2016, Vol. 11 Issue 1, p1 

    Purpose/Objectives: Treatment of the primary tumor reportedly improves survival in several types of metastatic cancer. We herein evaluated the efficacy and toxicity of radiotherapy for the primary tumor in prostate cancer with metastasis. Materials/Methods: The study cohort included 140 men...

  • Multiple primary malignancies in patients with prostate cancer: increased risk of secondary malignancies after radiotherapy. Okajima, Kaoru; Ishikawa, Kazuki; Matsuura, Tomohiro; Tatebe, Hitoshi; Fujiwara, Kazuhisa; Hiroi, Keiji; Hasegawa, Hirokazu; Nishimura, Yasumasa // International Journal of Clinical Oncology;Dec2013, Vol. 18 Issue 6, p1078 

    Background: New treatment strategies for prostate cancer have recently been developed, but multiple malignancies remain a major concern. The aim of this study was to evaluate the characteristics of multiple malignancies and to analyze the risk of secondary malignancies after radiotherapy for...

  • Phase i dose-escalation study of stereotactic body radiotherapy (SbRT) for organ confined prostate cancer. Ghaly, M.; Vijeh, L.; Montchal, E.; Marrero, M.; Potters, L. // Journal of Radiosurgery & SBRT;2013 Supplement 2.1, Vol. 2, p149 

    Purpose: To evaluate patient's tolerability of the initial dose levels in a dose-escalation study for localized prostate cancer, using linear accelerator-delivered SBRT. Patients and Methods: Patients included those with Gleason score < 7 with prostate-specific antigen (PSA) ≤ 10, Gleason...

  • Accumulated dose to the rectum, measured using dose-volume histograms and dose-surface maps, is different from planned dose in all patients treated with radiotherapy for prostate cancer. SCAIFE, JESSICA E.; THOMAS, SIMON J.; HARRISON, KARL; ROMANCHIKOVA, MARINA; SUTCLIFFE, MICHAEL P. F.; FORMAN, JULIA R.; BATES, AMY M.; JENA, RAJ; PARKER, M. ANDREW; BURNET, EIL G. // British Journal of Radiology;Oct2015, Vol. 88 Issue 1054, p1 

    Objective: We sought to calculate accumulated dose (DA) to the rectum in patients treated with radiotherapy for prostate cancer. We were particularly interested in whether dose-surface maps (DSMs) provide additional information to dose-volume histograms (DVHs). Methods: Manual rectal contours...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics